Personalized Antisense Oligonucleotide for Participants With CHCHD10 ALS
Clinical trial NCT07095686 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT07095686
- Sponsor
- n-Lorem Foundation
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-02
- Primary completion
- 2027-04-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.